Montelukast sodium市场规模、份额及成长分析（依产品类型、剂型、药物类别、应用、通路及地区）－2025-2032 年产业预测

2023 年全球Montelukast sodium市场规模为 4.582 亿美元，预计将从 2024 年的 5.2739 亿美元成长到 2032 年的 16.2455 亿美元，预测期内（2025-2032 年）的复合年增长率为 15.1%。

全球Montelukast sodium市场正经历显着成长，原因是空气污染加剧和老年人口增长导致气喘和过敏性鼻炎病例增加，尤其是在日本、德国和义大利等地区。随着医疗基础设施的改善和Montelukast被纳入治疗指南，对该药物的需求只会增加。製剂和联合治疗的技术创新进一步扩大了Montelukast的效用。此外，人工智慧、物联网和区块链等技术的进步正在透过加强药物发现、确保妥善储存和维护供应链的完整性来改变製药业。在全球慢性呼吸系统疾病日益增多的背景下，这些趋势使Montelukast sodium市场保持持续成长。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 二次资料和一次资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态与展望

• 市场概览
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

关键市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024年）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 定价分析
• 监管分析
• 技术分析
• 案例研究

Montelukast sodium市场规模（依产品类型）

• 市场概览
• 吸入器
  • 干粉
  • 定量喷雾型
  • 缓雾
• 喷雾器

Montelukast sodium市场规模（以剂型）

• 市场概览
• 药片
• 口服溶液
• 其他的

Montelukast sodium市场规模（依药物类别）

• 市场概览
• 消炎（药）
• 支气管扩张剂
• 联合治疗

Montelukast sodium市场规模（依应用）

• 市场概览
• 气喘
• 过敏性鼻炎
• 麻疹
• 其他用途

Montelukast sodium市场规模（依分销管道）

• 市场概览
• 医院药房
• 零售药局
• 网路药局

Montelukast sodium市场规模

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市场占有率分析（2024年）
• 主要企业简介
  • 公司详情
  • 产品系列分析
  • 公司分部份额分析
  • 收益同比对比（2022-2024 年）

主要企业简介

• Teva Pharmaceuticals USA Inc.（US）
• Merck & Co. Inc.（US）
• Cipla Limited（India）
• Morepen Laboratories（India）
• Sanofi Aventis SA（France）
• SUN PHARMA（India）
• Intas Pharmaceuticals Ltd（India）
• Delmar Chemicals Inc.（Canada）
• SK Capital（Apotex Inc）（Canada）
• Sanyo Chemical Industries Ltd（Japan）

结论和建议

Global Montelukast Sodium Market size was valued at USD 458.2 million in 2023 and is poised to grow from USD 527.39 million in 2024 to USD 1624.55 million by 2032, growing at a CAGR of 15.1% during the forecast period (2025-2032).

The global montelukast sodium market is experiencing significant growth driven by a rise in asthma and allergic rhinitis cases, stemming from increasing air pollution and a growing elderly population, particularly in regions like Japan, Germany, and Italy. As healthcare infrastructure improves and montelukast is incorporated into treatment guidelines, demand for this medication continues to rise. Innovations in drug formulations and combination therapies are further expanding its usability. Additionally, advancements in technology, such as artificial intelligence, IoT, and blockchain, are transforming the pharmaceutical sector by enhancing drug discovery, ensuring proper storage, and maintaining supply chain integrity. These trends position the montelukast sodium market for sustained growth amid rising chronic respiratory issues globally.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Montelukast Sodium market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Montelukast Sodium Market Segments Analysis

Global Montelukast Sodium Market is segmented by Product Type, Dosage Form, Drug Class, Application, Distribution Channel and region. Based on Product Type, the market is segmented into Inhalers and Nebulizers. Based on Dosage Form, the market is segmented into Tablets, Oral solutions and Others. Based on Drug Class, the market is segmented into Anti-inflammatory, Bronchodilators and Combination Therapy. Based on Application, the market is segmented into Asthma, Allergic rhinitis, Urticaria and Other applications. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Online pharmacies. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is being propelled by the rising incidence of respiratory disorders like asthma and allergic rhinitis, driven by various factors including air pollution, smoking, genetic factors, and shifts in lifestyle. As more people are diagnosed with chronic respiratory conditions linked to escalating air pollution, urbanization, climate change, and hereditary predispositions, there is a notable increase in demand for montelukast sodium. This growing recognition of the need for effective treatment options reflects the broader health trends and challenges contemporary societies face, ultimately contributing to the expansion of the montelukast sodium market on a global scale.

Restraints in the Global Montelukast Sodium Market

The global Montelukast Sodium market faces significant restraints due to the absence of patent protection, resulting in heightened competition among manufacturers. The presence of generic versions of Montelukast Sodium, often available at lower prices, adversely affects the sales of branded products. Additionally, the influx of inexpensive imported montelukast sodium further hampers the growth of domestic markets, making it challenging for local producers to compete effectively. This intense rivalry and price undercutting create a competitive landscape that restricts the potential expansion opportunities for established brands within the Montelukast Sodium sector, leading to a constrained market environment overall.

Market Trends of the Global Montelukast Sodium Market

The Global Montelukast Sodium market is witnessing a significant trend driven by patent expirations, leading to a surge in generic formulations that provide equivalent therapeutic benefits at reduced prices. This shift is favored by patients, healthcare practitioners, and government health systems seeking cost-effective treatment options. As more pharmaceutical companies enter the market, increased competition is fostering innovation and accessibility in montelukast sodium products. Meanwhile, regulatory authorities continue to implement stringent approval processes for generics, ensuring safety and efficacy. This multifaceted landscape is reshaping the market dynamics, ultimately benefiting end-users while expanding the global reach of montelukast sodium.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Case Studies

Global Montelukast Sodium Market Size by Product Type & CAGR (2025-2032)

• Market Overview
• Inhalers
  • Dry Powder
  • Metered Dose
  • Soft Mist
• Nebulizers

Global Montelukast Sodium Market Size by Dosage Form & CAGR (2025-2032)

• Market Overview
• Tablets
• Oral solutions
• Others

Global Montelukast Sodium Market Size by Drug Class & CAGR (2025-2032)

• Market Overview
• Anti-inflammatory
• Bronchodilators
• Combination Therapy

Global Montelukast Sodium Market Size by Application & CAGR (2025-2032)

• Market Overview
• Asthma
• Allergic rhinitis
• Urticaria
• Other applications

Global Montelukast Sodium Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital pharmacies
• Retail pharmacies
• Online pharmacies

Global Montelukast Sodium Market Size & CAGR (2025-2032)

• North America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • US
  • Canada
• Europe (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Dosage Form, Drug Class, Application, Distribution Channel)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Teva Pharmaceuticals USA Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck & Co. Inc. (U.S.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cipla Limited (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Morepen Laboratories (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi Aventis SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SUN PHARMA (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Intas Pharmaceuticals Ltd (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Delmar Chemicals Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SK Capital (Apotex Inc) (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanyo Chemical Industries Ltd (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations